Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹5325 Cr.
Stock P/E
51.3
P/B
5.9
Current Price
₹336.4
Book Value
₹ 56.7
Face Value
1
52W High
₹378.4
52W Low
₹ 202.9
Dividend Yield
0.13%

Artemis MedicareServ Overview

Business

Artemis Medicare Services Ltd. is a leading private healthcare provider primarily operating in India. The company owns and operates multi-specialty tertiary care hospitals, with its flagship facility located in Gurugram, Haryana. Its core business model revolves around providing comprehensive medical services across various specialties including cardiology, oncology, neurosciences, orthopaedics, gastroenterology, and emergency medicine. Artemis generates revenue primarily through patient services, including inpatient admissions, outpatient consultations, diagnostic tests, surgical procedures, and pharmacy sales. It caters to both domestic and international patients.

Revenue Mix

The company's revenue is predominantly derived from its hospital operations. While specific revenue mix percentages for different specialties are not consistently public, the primary streams include:

Inpatient Services: Admissions for complex medical conditions, surgeries, and long-term care.

Outpatient Services: Consultations, day care procedures, and follow-up visits.

Diagnostics: Laboratory tests and imaging services (e.g., MRI, CT scans).

Pharmacy: In-hospital pharmacy sales to patients.

The company operates primarily through its flagship hospital and aims for high utilization across its bed capacity.

Industry

The Indian hospital and healthcare services industry is large, growing, and fragmented, with a mix of large corporate chains, smaller regional players, and standalone hospitals. It is driven by factors like increasing health consciousness, rising disposable incomes, improving insurance penetration, and medical tourism. Artemis Medicare Services Ltd. is positioned as a quality-focused, tertiary care provider, particularly strong in the Delhi-NCR region. It competes with other established corporate hospital chains like Max Healthcare, Fortis Healthcare, Apollo Hospitals, and Medanta, distinguishing itself through its emphasis on medical technology, clinical expertise, and patient experience. Its single-hospital focus (primarily Gurugram) gives it deep roots in that market but limits its national footprint compared to multi-city chains.

MOAT

Brand & Reputation: Artemis has built a strong brand reputation in the Gurugram and Delhi-NCR region for specialized medical care, particularly in certain high-end specialties. This attracts both local and international patients.

Clinical Excellence & Talent: A focus on attracting and retaining highly skilled medical professionals and adopting advanced medical technologies contributes to its service quality.

Infrastructure & Accreditation: Its modern infrastructure and NABH accreditation underscore its commitment to quality and patient safety, which can act as a differentiator.

Regional Concentration: While not a national scale, its strong concentration and established presence in a key metropolitan area allow for deeper market penetration and operational efficiencies within that region.

Growth Drivers

Rising Healthcare Expenditure: Increasing per capita healthcare spending and health insurance penetration in India.

Medical Tourism: Gurugram's proximity to Delhi makes it a hub for medical tourism, attracting international patients for high-quality, cost-effective treatment.

Demographic Shifts & Disease Burden: Growing elderly population and increasing prevalence of non-communicable diseases (NCDs) create sustained demand for specialized tertiary care.

Infrastructure Expansion: Potential for bed capacity expansion or adding new specialized units within its existing or future facilities.

Digital Health Integration: Adoption of telemedicine and digital health platforms to improve patient access and operational efficiency.

Risks

Intense Competition: Highly competitive market with established players and new entrants leading to pricing pressures and talent wars.

Regulatory & Policy Changes: The healthcare sector is subject to stringent regulations, and changes in pricing caps, quality standards, or accreditation norms can impact profitability.

Talent Retention: Attracting and retaining skilled doctors, nurses, and allied healthcare professionals is crucial and can lead to high employee costs.

High Capital Expenditure: Setting up and maintaining modern hospitals requires significant capital investment and ongoing technology upgrades.

Medical Malpractice & Litigation: Risk of medical errors and associated legal liabilities, which can harm reputation and finances.

Disease Outbreaks: Pandemics or epidemics can significantly impact patient footfall for elective procedures and operational costs.

Management & Ownership

Artemis Medicare Services Ltd. is promoted by the Emami Group, a diversified Indian conglomerate with interests across various sectors. The promoter group holds a significant stake, indicating their long-term commitment to the business. The management team consists of experienced professionals from the healthcare industry, overseeing operations, clinical excellence, and strategic growth initiatives. The presence of a well-established promoter group often lends credibility and financial backing.

Outlook

Artemis Medicare Services Ltd. is well-positioned to benefit from the robust growth in India's healthcare sector, driven by increasing demand for quality medical services, rising health awareness, and the potential for medical tourism. Its strong brand presence and clinical focus in the Delhi-NCR region provide a solid foundation. However, the company operates in a highly competitive and capital-intensive industry, facing challenges such as intense competition, evolving regulatory landscape, and the constant need for technological upgrades and talent retention. Its ability to expand strategically, optimize operational efficiencies, and maintain its clinical reputation will be key to its sustained growth and profitability amidst a dynamic market.

Artemis MedicareServ Share Price

Live · BSE / NSE · Inception: 2004
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Artemis MedicareServ Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 225 223 241 232 240 255 275 272 279 287
Other Income 2 4 7 9 12 7 8 7 8 5
Total Income 227 228 249 241 252 262 282 280 287 293
Total Expenditure 187 187 199 195 204 214 224 228 228 231
Operating Profit 40 41 50 46 48 48 58 52 59 62
Interest 9 8 8 8 8 7 7 7 6 6
Depreciation 11 11 11 11 12 11 12 12 13 13
Exceptional Income / Expenses 0 0 0 0 0 0 0 -3 0 0
Profit Before Tax 20 22 31 27 29 30 39 30 40 43
Provision for Tax 6 5 8 6 6 9 9 8 10 11
Profit After Tax 14 17 22 21 23 21 30 22 30 31
Adjustments -0 0 0 0 0 0 -0 0 -0 -0
Profit After Adjustments 14 17 22 21 23 21 30 22 30 31
Adjusted Earnings Per Share 1 1.2 1.6 1.5 1.7 1.5 2.2 1.4 1.9 2

Artemis MedicareServ Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 547 565 408 555 737 879 937 1081 1113
Other Income 4 5 4 5 7 7 33 30 28
Total Income 551 570 412 560 745 886 970 1111 1142
Total Expenditure 483 504 373 488 643 746 785 893 911
Operating Profit 68 66 39 71 101 140 185 218 231
Interest 11 13 13 12 20 31 32 28 26
Depreciation 20 23 22 22 31 40 45 48 50
Exceptional Income / Expenses 0 0 3 0 0 0 0 -3 -3
Profit Before Tax 37 31 8 37 51 68 108 139 152
Provision for Tax 16 11 1 6 13 19 25 35 38
Profit After Tax 20 19 6 31 38 49 82 104 113
Adjustments 0 0 0 0 1 -0 0 -0 0
Profit After Adjustments 20 20 6 32 39 49 83 104 113
Adjusted Earnings Per Share 0 1.5 0.5 2.4 2.9 3.6 6 6.5 7.5

Artemis MedicareServ Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 293 313 320 359 403 448 838 935
Minority's Interest -0 0 2 2 5 6 6 6
Borrowings 53 66 108 161 214 228 209 190
Other Non-Current Liabilities 31 49 61 65 103 135 130 137
Total Current Liabilities 177 158 118 138 206 185 216 240
Total Liabilities 554 586 609 726 930 1002 1399 1508
Fixed Assets 381 393 383 489 605 719 745 804
Other Non-Current Assets 61 76 116 110 155 103 120 308
Total Current Assets 113 118 109 127 170 180 535 396
Total Assets 554 586 609 726 930 1002 1399 1508

Artemis MedicareServ Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 4 9 12 19 16 23 15 42
Cash Flow from Operating Activities 40 56 27 60 127 109 156 132
Cash Flow from Investing Activities -50 -26 -37 -107 -158 -88 -393 -90
Cash Flow from Financing Activities 14 -27 18 44 38 -29 264 -50
Net Cash Inflow / Outflow 5 2 8 -3 7 -8 27 -8
Closing Cash & Cash Equivalent 9 12 19 16 23 15 42 33

Artemis MedicareServ Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0 1.5 0.49 2.4 2.88 3.62 6 6.55
CEPS(Rs) 0 3.18 2.09 4.05 5.15 6.58 9.25 9.59
DPS(Rs) 0 0 0 0 0.45 0.45 0.45 0.45
Book NAV/Share(Rs) 0 18.68 19.17 21.51 24.43 27.52 55.63 54.69
Core EBITDA Margin(%) 11.68 10.88 8.62 11.98 12.74 15.1 16.2 17.4
EBIT Margin(%) 8.74 7.69 5.01 8.86 9.53 11.35 14.9 15.43
Pre Tax Margin(%) 6.72 5.42 1.84 6.7 6.86 7.79 11.49 12.87
PAT Margin (%) 3.73 3.44 1.51 5.66 5.15 5.59 8.77 9.59
Cash Profit Margin (%) 7.4 7.45 6.78 9.66 9.36 10.18 13.59 14.04
ROA(%) 3.68 3.41 1.03 4.71 4.59 5.09 6.84 7.14
ROE(%) 9.5 8.43 2.46 11.66 12.41 14.01 14.43 12.72
ROCE(%) 13.96 12.64 5.63 11.47 13.34 16.47 16.93 15.83
Receivable days 52.5 50.13 58.68 42.15 41.25 39.07 38.21 37.29
Inventory Days 4.63 5.71 9.11 7.24 6.53 5 3.91 3.95
Payable days 205.99 194.88 206.67 138.01 141.52 152.49 156.98 143.48
PER(x) 0 9.23 45.31 19.1 23.65 46.95 45.76 31.36
Price/Book(x) 0 0.74 1.16 2.13 2.79 6.17 4.94 3.75
Dividend Yield(%) 0 0 0 0 0.66 0.27 0.16 0.22
EV/Net Sales(x) 0.19 0.47 0.96 1.38 1.5 2.84 3.88 3.02
EV/Core EBITDA(x) 1.5 4.01 10.07 10.7 10.89 17.84 19.65 15
Net Sales Growth(%) 0 3.39 -27.72 35.85 32.92 19.14 6.64 15.4
EBIT Growth(%) 0 -9.04 -52.9 140.33 42.97 41.91 39.98 19.52
PAT Growth(%) 0 -4.55 -68.35 409.76 21.05 29.29 67.21 26.21
EPS Growth(%) 0 0 -67.23 390.47 19.75 25.68 66.01 9.01
Debt/Equity(x) 0.53 0.4 0.5 0.64 0.74 0.68 0.32 0.26
Current Ratio(x) 0.64 0.74 0.92 0.92 0.83 0.98 2.48 1.65
Quick Ratio(x) 0.6 0.68 0.84 0.83 0.76 0.92 2.43 1.6
Interest Cover(x) 4.34 3.39 1.58 4.11 3.57 3.19 4.37 6.03
Total Debt/Mcap(x) 0 0.54 0.43 0.3 0.26 0.11 0.07 0.07

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +15% +14% +22% —
Operating Profit CAGR +18% +29% +41% —
PAT CAGR +27% +40% +77% —
Share Price CAGR +43% +30% +56% —
ROE Average +13% +14% +13% +11%
ROCE Average +16% +16% +15% +13%

Artemis MedicareServ Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 58.39 %
FII 12.29 %
DII (MF + Insurance) 8.56 %
Public (retail) 20.76 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 68.0367.5167.1767.1767.1766.5366.5358.3958.3958.39
FII 0.10.160.220.640.310.240.3712.4712.1912.29
DII 9.7810.5710.6911.5912.1311.7811.299.079.058.56
Public 22.0821.7621.9220.620.3921.4621.8120.0820.3720.76
Others 0000000000
Total 100100100100100100100100100100

Artemis MedicareServ Peer Comparison

Hospital & Healthcare Services Edit Columns

Artemis MedicareServ Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Artemis MedicareServ Pros & Cons

Pros

  • Company has delivered good profit growth of 76% CAGR over last 5 years
  • Debtor days have improved from 156.98 to 143.48days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 14% over the last 3 years.
  • Stock is trading at 5.9 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp